Company Profiles

driven by the PitchBook Platform

Arcus Biosciences

Arcus Biosciences
2015 FOUNDED
PRIVATE STATUS
51-200 EMPLOYEES
Series B LATEST DEAL TYPE
$70M LATEST DEAL AMOUNT
$120M TOTAL AMOUNT RAISED
Description

Developer of innovative cancer immunotherapies designed to treat cancer. The company's innovative cancer immunotherapies targets one or more therapeutic nodes and discover drugs that block tumors' ability to highjack the immune system, enabling patients to recover cancer.

Website:
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
3928 Point Eden Way
Hayward, CA 94545
United States

+1 (510) 694-6200
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Arcus Biosciences’s full profile, request a free trial.

Arcus Biosciences Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series B) 29-Aug-2016 $70M $120M 00000 Completed Startup
2. Early Stage VC (Series A) 14-Aug-2015 000.00 000.00 000.00 Completed Startup
1. Angel (individual) Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Arcus Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series B 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A 00,000,000 00.000000 00.00 00 00 00 00 00.000
To view this company’s complete Cap Table request access »

Arcus Biosciences Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Celgene Corporation Minority 000 0000 000000 0
Droia Oncology Ventures Venture Capital Minority 000 0000 000000 0
GV Corporate Venture Capital Minority 000 0000 000000 0
Invus Group PE/Buyout Minority 000 0000 000000 0
Karl Handelsman Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »

Arcus Biosciences Executive Team (8)

Name Title Board
Seat
Contact
Info
Terry Rosen Ph.D Co-Founder and Chief Executive Officer
Juan Jaen Ph.D Co-Founder & President
Jennifer Jarrett Chief Business Officer and Chief Financial Officer
Jay Powers Ph.D Vice President, Drug Discovery
Ulrike Schindler Vice President of Biology
You’re viewing 5 of 8 executives. Get the full list »